A. Colombey

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis.

L. Arnaud, A. Korganow, J. Sibilia, 2019, Seminars in arthritis and rheumatism.

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry

X. Mariette, J. Gottenberg, J. Avouac, 2021, The Lancet Rheumatology.